Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104169 · ClinicalTrials.gov registry record · Phase 2
Idiopathic Anemia of Aging (IAA)
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00104169 is a Phase 2 study that was terminated before completion, run by National Institute on Aging (NIA).
The verdict
NCT00104169, a Phase 2 study, was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
Interventions
- DRUG Epoetin Alfa
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00104169
The ClinicalTrials.gov registry entry for NCT00104169 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epoetin Alfa is the first listed.
NCT00104169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00104169 about?
NCT00104169 is a clinical study titled "Idiopathic Anemia of Aging (IAA)". The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
What is the current status of trial NCT00104169?
This trial is currently terminated. It is a Phase 2 study. The study started on 2004-08. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00104169?
The interventions under investigation include: Epoetin Alfa (DRUG).
Who is sponsoring clinical trial NCT00104169?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.